NZ256300A - Administration of beta-hydroxy-beta-methyl butyric acid, or its convertible forms, to lower cholesterol levels - Google Patents

Administration of beta-hydroxy-beta-methyl butyric acid, or its convertible forms, to lower cholesterol levels

Info

Publication number
NZ256300A
NZ256300A NZ256300A NZ25630093A NZ256300A NZ 256300 A NZ256300 A NZ 256300A NZ 256300 A NZ256300 A NZ 256300A NZ 25630093 A NZ25630093 A NZ 25630093A NZ 256300 A NZ256300 A NZ 256300A
Authority
NZ
New Zealand
Prior art keywords
hmb
cholesterol
ldl
beta
hydroxy
Prior art date
Application number
NZ256300A
Other languages
English (en)
Inventor
Steven Lynn Nissen
Original Assignee
Univ Iowa State Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25484425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ256300(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Iowa State Res Found Inc filed Critical Univ Iowa State Res Found Inc
Publication of NZ256300A publication Critical patent/NZ256300A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NZ256300A 1992-09-16 1993-09-15 Administration of beta-hydroxy-beta-methyl butyric acid, or its convertible forms, to lower cholesterol levels NZ256300A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94640492A 1992-09-16 1992-09-16

Publications (1)

Publication Number Publication Date
NZ256300A true NZ256300A (en) 1997-06-24

Family

ID=25484425

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ256300A NZ256300A (en) 1992-09-16 1993-09-15 Administration of beta-hydroxy-beta-methyl butyric acid, or its convertible forms, to lower cholesterol levels

Country Status (12)

Country Link
US (1) US5360613A (https=)
EP (1) EP0660706B1 (https=)
JP (1) JP3148243B2 (https=)
AU (1) AU673002B2 (https=)
BR (1) BR9307035A (https=)
CA (1) CA2142314C (https=)
DE (1) DE69327468T2 (https=)
ES (1) ES2142353T3 (https=)
FI (1) FI951218A0 (https=)
NO (1) NO951000L (https=)
NZ (1) NZ256300A (https=)
WO (1) WO1994006417A1 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US6103764A (en) * 1997-11-07 2000-08-15 Iowa State University Research Foundation, Inc. Method for increasing the aerobic capacity of muscle
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
AU2620600A (en) * 1999-01-21 2000-08-07 Steroidogenesis Inhibitors International Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
BR0209820A (pt) * 2001-05-18 2004-06-01 Lonza Ag Processo para a preparação de formulações sólidas de 3-hidróxi-3-metilbutirato de sódio
US20040220266A1 (en) * 2002-09-09 2004-11-04 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
US6812249B2 (en) * 2003-03-04 2004-11-02 Sal Abraham Process for preparing a 3-hydroxy-3-methylbutyrate amino acid salt and method of use
EP1750527A1 (en) * 2004-03-11 2007-02-14 Wiley Organics, Inc. Compositions and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
WO2007056176A2 (en) * 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions for preventing and reducing delayed onset muscle soreness
JP5227182B2 (ja) 2005-12-19 2013-07-03 アボット・ラボラトリーズ １型および２型サイトカイン産生における不均衡を調節するためのベータ−ヒドロキシ−ベータ−メチルブチラートの使用
US20080200422A1 (en) * 2007-01-09 2008-08-21 Cavener Douglas R Methods for reduction of adipose tissue mass
US11173167B2 (en) 2008-12-09 2021-11-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9259430B2 (en) 2008-12-09 2016-02-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9539224B2 (en) 2008-12-09 2017-01-10 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9707241B2 (en) 2008-12-09 2017-07-18 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9770424B2 (en) 2008-12-09 2017-09-26 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
WO2010068696A1 (en) 2008-12-09 2010-06-17 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US8538727B2 (en) * 2009-07-21 2013-09-17 George S. Cembrowski Method and apparatus for calibration and testing of scientific measurement equipment
US11042605B2 (en) 2009-07-21 2021-06-22 Ccqcc Corp. Method and apparatus for calibration and testing of scientific measurement equipment
ES2481865T3 (es) 2010-01-29 2014-07-31 Abbott Laboratories Emulsiones nutricionales que comprenden HMB de calcio
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
BR112012018174A2 (pt) 2010-01-29 2019-08-27 Abbott Lab líquidos nutricionais embalados assepticamente compreendendo hmb.
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
RU2631597C2 (ru) * 2011-07-15 2017-09-25 Нусерт Сайенсиз, Инк. Композиции и способы модулирования метаболических путей
JP2014525410A (ja) * 2011-08-15 2014-09-29 アボット・ラボラトリーズ Ｈｍｂ及びその塩を製造する方法
US9327001B2 (en) 2011-11-03 2016-05-03 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
WO2012140276A2 (en) * 2011-11-17 2012-10-18 Lonza Ltd Process for the preparation of 3-hydroxy-3-methylbutyric acid or its calcium salts
US10092590B2 (en) 2012-09-10 2018-10-09 Metabolic Technologies, Inc. Composition of HMB and ATP and methods of use
WO2015148982A1 (en) 2014-03-27 2015-10-01 Winterfield Roland W Beta-hydroxy beta-methylbutyrate for alleviating statin myopathy
PT3349745T (pt) 2015-09-16 2024-03-18 Metabolic Tech Inc Composições e métodos de utilização de beta-hidroxi-beta metilbutirato (hmb) para melhorar a recuperação de traumatismos de tecidos moles
US12208073B2 (en) 2015-09-16 2025-01-28 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma
CN108473411B (zh) * 2015-11-19 2022-08-12 协和发酵生化株式会社 3-羟基异戊酸的一价阳离子盐的晶体及该晶体的制造方法
WO2017127675A1 (en) 2016-01-21 2017-07-27 Metabolic Technololgies, Inc. COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) FOR MODULATING AUTOPHAGY AND LIPOPHAGY
CA3028608A1 (en) 2016-06-24 2017-12-28 Otsuka Pharmaceutical Factory, Inc. Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof
HUE069527T2 (hu) 2016-10-21 2025-03-28 Metabolic Tech Llc Béta-hidroxi-béta-metil-butirát (HMB) és probiotikumok kompozíciói és alkalmazási eljárásai

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629449A (en) * 1968-04-22 1971-12-21 Majid Siddiqi Process of combatting hypercholesterolemia
US4764531A (en) * 1986-03-11 1988-08-16 Iowa State University Research Foundation, Inc. Method of feeding ketoisocaproate to laying chickens
US4760090A (en) * 1986-03-11 1988-07-26 Iowa State University Research Foundation, Inc. Method of feeding ketoisocaproate to cattle and sheep
US5087472A (en) * 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US5028440A (en) * 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US4992470A (en) * 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals

Also Published As

Publication number Publication date
WO1994006417A1 (en) 1994-03-31
JPH08501777A (ja) 1996-02-27
CA2142314C (en) 1999-06-01
FI951218A7 (fi) 1995-03-15
FI951218L (fi) 1995-03-15
CA2142314A1 (en) 1994-03-31
EP0660706A1 (en) 1995-07-05
JP3148243B2 (ja) 2001-03-19
DE69327468T2 (de) 2000-05-11
EP0660706A4 (https=) 1995-07-26
ES2142353T3 (es) 2000-04-16
EP0660706B1 (en) 1999-12-29
NO951000D0 (no) 1995-03-15
BR9307035A (pt) 1999-06-29
FI951218A0 (fi) 1995-03-15
AU673002B2 (en) 1996-10-24
AU4922593A (en) 1994-04-12
DE69327468D1 (de) 2000-02-03
US5360613A (en) 1994-11-01
NO951000L (no) 1995-03-15

Similar Documents

Publication Publication Date Title
AU673002B2 (en) Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol
EP0637239B1 (en) Use of beta-hydroxy-beta-methylbutyric acid for promoting nitrogen retention in humans
RU2221558C2 (ru) Новые аналоги жирных кислот для лечения диабета
US5998421A (en) Lipid metabolism ameliorants
US20120004157A1 (en) Hydroxyproline compositions and uses thereof
JPH0662758A (ja) バイオマスの利用
EA025256B1 (ru) Композиция, подходящая для лечения нарушений липидного обмена
EP0916342B1 (en) A medicament for treating obesity and improving lipid metabolism
US5240962A (en) Antiobesity and fat-reducing agents
CA2425773A1 (en) Compositions for improving lipid metabolism
JP3858055B2 (ja) 抗肥満剤及び脂質代謝改善剤
WO2005123056A1 (en) Use of alpha-ketoglutarate and related compounds for lowering plasma lipids
Sebrell Fatty Degeneration of the Liver and Kidneys in the Dog Apparently Associated with Diet: A Preliminary Note
US6531462B2 (en) Medicament for treating obesity and improving lipid metabolism
Shaklee Research on cholesterol in poultry and eggs in the United States
Maclean et al. The effect of high protein diet on renal function
JPS61151129A (ja) ビタミンｅ吸収促進剤
US4093746A (en) Method of and fodder for rearing white-meat calves for slaughter
Rose Physiological responses of cockerels to dietary protein and energy restriction
Bhatia Effects of pregnancy and ovarian steroids on energy balance in Syrian hamsters
JPH0453845B2 (https=)
KR20020017482A (ko) 면역항체증강제

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired